Semaglutide may be a good starting option for individuals beginning GLP-1 treatment, while tirzepatide may be considered when additional appetite control or metabolic support is needed
When it arrives, inspect the packaging immediately
Coz Yataco and Simpson, 2020
Potential Interactions Between These Two Medicines No formal interaction studies exist, but pharmacodynamic interactions are a key concern tesamorelin raises blood glucose whilst retatrutide lowers it, making the combined glycaemic effect unpredictable and requiring close clinical monitoring
Final point I love this tiny footnote they have about the shortage ending in their investor presentation: As always, we will continue to monitor and comply with regulatory requirements related to the GLP-1 shortages
If you miss a dose, skip it and take the next dose the following day